Solvonis Therapeutic reports vital patent milestone achieved for SVN 114
Solvonis Therapeutics PLC said a vital patent milestone has been achieved for SVN 114, according to an RNS announcement dated 03 September 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.